This process indicates that supplementation with vitamin D and A in MS patients might improve MS by triggering an anti-inflammatory cascade suggested by the increase of IL-10+ CD4 T cells, and decreased ratio of IFN-γ+/IL-14+ T cells (72, 73). This evidence concerns the gene IFNG and myeloid sarcoma.